ARDELYX INC

For the period ended Mar 31, 2025. Filed May 1, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 1, 2025

ARDX$3.01+2.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Statements of Operations and Comprehensive Loss

(in thousands, except share and per share amounts)

	Three Months Ended March 31,
	2025	2024
Revenues
Product sales, net	$67,814	$43,512
Product supply revenue	254	2,126
Licensing revenue	5,020	17
Non-cash royalty revenue related to the sale of future royalties	1,026	368
Total revenues	74,114	46,023
Cost of goods sold
Cost of product sales	2,340	1,013
Other cost of revenue	9,963	6,115
Total cost of goods sold	12,303	7,128
Operating expenses
Research and development	14,938	10,579
Selling, general and administrative	83,222	52,994
Total operating expenses	98,160	63,573
Loss from operations	(36,349)	(24,678)
Interest expense	(4,191)	(2,356)
Non-cash interest expense related to the sale of future royalties	(2,071)	(1,702)
Other income, net	2,326	2,339
Loss before provision for income taxes	(40,285)	(26,397)
Provision for income taxes	859	121
Net loss	$(41,144)	$(26,518)
Net loss per share of common stock - basic and diluted	$(0.17)	$(0.11)
Shares used in computing net loss per share - basic and diluted	238,624,145	233,065,960
Comprehensive loss
Net loss	$(41,144)	$(26,518)
Unrealized losses on available-for-sale securities	(39)	(244)
Comprehensive loss	$(41,183)	$(26,762)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.